These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 8880939)

  • 21. Effects of the antidepressant/antipanic drug phenelzine on alanine and alanine transaminase in rat brain.
    Tanay VA; Parent MB; Wong JT; Paslawski T; Martin IL; Baker GB
    Cell Mol Neurobiol; 2001 Aug; 21(4):325-39. PubMed ID: 11775064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic administration of antipanic drugs alters rat brainstem GABAA receptor subunit mRNA levels.
    Tanay VA; Glencorse TA; Greenshaw AJ; Baker GB; Bateson AN
    Neuropharmacology; 1996; 35(9-10):1475-82. PubMed ID: 9014163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of phenelzine and imipramine on the steady-state levels of mRNAs that encode glutamic acid decarboxylase (GAD67 and GAD65), the GABA transporter GAT-1 and GABA transaminase in rat cortex.
    Lai CT; Tanay VA; Charrois GJ; Baker GB; Bateson AN
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Jan; 357(1):32-8. PubMed ID: 9459570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of moclobemide on the yohimbine-induced anxiogenic action in the elevated plus-maze.
    Eroğlu L; Güven O
    Pharmacol Res; 1998 Feb; 37(2):137-43. PubMed ID: 9572069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Common effects of chronically administered antipanic drugs on brainstem GABA(A) receptor subunit gene expression.
    Tanay VM; Greenshaw AJ; Baker GB; Bateson AN
    Mol Psychiatry; 2001 Jul; 6(4):404-12. PubMed ID: 11443524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.
    Alemany R; Olmos G; García-Sevilla JA
    Br J Pharmacol; 1995 Feb; 114(4):837-45. PubMed ID: 7773544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo evidence for reduced cortical glutamate-glutamine cycling in rats treated with the antidepressant/antipanic drug phenelzine.
    Yang J; Shen J
    Neuroscience; 2005; 135(3):927-37. PubMed ID: 16154287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-lasting elevation of alanine in brain produced by the antidepressant phenelzine.
    Wong JT; Baker GB; Coutts RT; Dewhurst WG
    Brain Res Bull; 1990 Jul; 25(1):179-81. PubMed ID: 2207706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent studies on the MAO inhibitor phenelzine and its possible metabolites.
    McKenna KF; Baker GB; Coutts RT; Rauw G; Mozayani A; Danielson TJ
    J Neural Transm Suppl; 1990; 32():113-8. PubMed ID: 1982447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-adrenoceptors and antidepressants: possible 2-phenylethylamine mediation of chronic phenelzine effects.
    McManus DJ; Mousseau DD; Paetsch PR; Wishart TB; Greenshaw AJ
    Biol Psychiatry; 1991 Dec; 30(11):1122-30. PubMed ID: 1663791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stress reduces in vivo inhibition of monoamine oxidase by phenelzine in rat brain.
    Clow A; Glover V; Oxenkrug GF; Sandler M
    Neurosci Lett; 1989 Dec; 107(1-3):331-4. PubMed ID: 2616044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevation of rat brain tyrosine levels by phenelzine is mediated by its active metabolite β-phenylethylidenehydrazine.
    Matveychuk D; Nunes E; Ullah N; Aldawsari FS; Velázquez-Martínez CA; Baker GB
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Aug; 53():67-73. PubMed ID: 24607770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Depletion of brain norepinephrine: differential influence on anxiolyic treatment effects.
    Fontana DJ; McMiller LV; Commissaris RL
    Psychopharmacology (Berl); 1999 Apr; 143(2):197-208. PubMed ID: 10326783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Profiles of the antipanic compounds, triazolobenzodiazepines and phenelzine, in two animal tests of anxiety.
    Johnston AL; File SE
    Psychiatry Res; 1988 Jul; 25(1):81-90. PubMed ID: 3217470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Befloxatone, a new reversible and selective monoamine oxidase-A inhibitor. II. Pharmacological profile.
    Caille D; Bergis OE; Fankhauser C; Gardes A; Adam R; Charieras T; Grosset A; Rovei V; Jarreau FX
    J Pharmacol Exp Ther; 1996 Apr; 277(1):265-77. PubMed ID: 8613929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatments.
    Balu DT; Hoshaw BA; Malberg JE; Rosenzweig-Lipson S; Schechter LE; Lucki I
    Brain Res; 2008 May; 1211():37-43. PubMed ID: 18433734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of long-term administration of antidepressants on septal driving of hippocampal RSA.
    Zhu XO; McNaughton N
    Int J Neurosci; 1994 Nov; 79(1-2):91-8. PubMed ID: 7744554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of two substituted hydrazine monoamine oxidase (MAO) inhibitors on neurotransmitter amines, gamma-aminobutyric acid, and alanine in rat brain.
    Yamada N; Takahashi S; Todd KG; Baker GB; Paetsch PR
    J Pharm Sci; 1993 Sep; 82(9):934-7. PubMed ID: 7901387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antidepressant phenelzine alters differentiation of cultured human and mouse preadipocytes.
    Chiche F; Le Guillou M; Chétrite G; Lasnier F; Dugail I; Carpéné C; Moldes M; Fève B
    Mol Pharmacol; 2009 May; 75(5):1052-61. PubMed ID: 19201819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of chronic deuterated and non-deuterated phenelzine on rat brain monoamines and monoamine oxidase.
    Dyck LE; Juorio AV; Durden DA; Boulton AA
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Mar; 337(3):279-83. PubMed ID: 3393230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.